Management of alopecia in oncologic treatment patients

Karine Corcione Turke, Jose Roberto Fraga Neto, Deli Brito de Oliveira, Laissa Arruda Pinto, Jean Schoueri, Vanessa Salzano, Dolores Gonzalez Fabra


Introduction: The treatment of cancer has been evolving every day. However, adverse effects such as dermatological changes have a great psychosocial impact on cancer patients. One dermatological change is alopecia, characterized by loss of eyebrow and scalp strands. Case report: Two cases of patients undergoing chemotherapy with partial and total alopecia were reported. Both were treated with Minoxidil, which was topically used, with complete repilation after three months. No adverse effects observed. Conclusion: Minoxidil topical lotion has proven to be an effective and safe method to treat partial and total alopecia in patients still undergoing cancer treatment.


alopecia; Integrative oncology; dermatology; drug therapy


Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014;136:E359-86.

Fabra DG, Kayo AP, Leal ARO, Salzano V, Guglielmino F. Alterações dermatológicas em pacientes oncológicos- adultos e crianças. Arq Bras Ciên Saúde. 2009;34(2):87-93.

Cubero DIG, Abdalla BMZ, Schoueri J, Lopes FI, Turke KC, Guzman J, et al. Cutaneous side effects of molecularly targeted therapies for the treatment of solid tumors. Drugs in Context. 2018;7:212516.

Choi EK, Kim IR, Chang O, Kang D, Nam SJ, Lee JE, et al. Impact of chemotherapy-induced alopecia distress on body image, psychosocial well-being and depression in breast cancer patients. Psychooncology. 2014;23(10):1103-10.

Freites-Martinez A, Shapiro J, Chan D, Fornier M, Modi S, Gajria D, et al. Endocrine therapy-induced alopecia in patients with breast cancer. JAMA Dermatol. 2018;154(6):670-5.

Fabra DG, Salzano V, Guglielnino F, Kayo AP. Impacto do ambuatório de reabilitação dermatocosmiátrica na qualidade de vida dos pacientes oncológicos da Faculdade de Medicina do ABC. Arq Bras Ciên Saúde. 2010:35(2):89-94.

Trueb RM. Chemotherapy-induced alopecia. Semin Cutan Med Surg. 2009;28:11-14.

Grevelman EG, Breed WPM. Prevention of chemotherapy- induced hair loss by scalp cooling. Ann Oncol. 2005;16(3):352-8.

Shin H, Jo SJ, Kim DH, Kwon O, Myung SK. Efficacy of interventions for prevention of chemotherapy-induced alopecia: a systematic reviwe and meta-analysis. Int J Cancer. 2015;136(5):E442-54.

Barbareschi M. The use of minoxidil in the treatment of male and female androgenetic alopecia: a story of more than 30 year. G Ital Dermatol Venereol. 2018;153(1):102-6.

Rey MCW, Bonamigo RR. Tratamento de alopecia areata. Med Cutánea Iber Lat Am. 2006;34(2):49-52.

Messenger AG, Rundegren J. Minoxidil: mechanisms of action on hair growth. Br J Dermatol. 2004;150(2):186-94.

Headington JT. Hair follicle biology and topical minoxidil: possible mechanisms of action. Dermatologica. 1987;175(2):19-22.

Lucky AW, Piacquadio DJ, Ditre CM, Dunlap F, Kantor I, Pandya AG, et al. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. J Am Acad Dermatol. 2004;50(4):541-53.

Rossi A, Cantisani C, Melis L, Iorio A, Scali E, Calvieri S. Minoxidil use in dermatology, side effects and recent patents. Recent Pat inflamm Allergy Drug Discov. 2012;6(2):130-6.



  • There are currently no refbacks.

Copyright (c) 2019 Karine Corcione Turke, Jose Roberto Fraga Neto, Deli Brito de Oliveira, Laissa Arruda Pinto, Vanessa Salzano, Dolores Gonzalez Fabra

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.